“Hypoxic radioresistance” is commonly used to explain the correlation between anemia and cancer progression, and several interventions have been investigated to overcome hypoxia-induced radiation resistance, including hyperbaric oxygenation, erythropoietin injection, blood transfusion and drug therapy [15, 26]. The gene discussed is EPO; the disease is cancer.